CME Group Total Operating Expenses decreased by 9.3% to $570.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.8%, from $534.30M to $570.40M. Over 4 years (FY 2021 to FY 2025), Total Operating Expenses shows an upward trend with a 2.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Rising expenses without a corresponding rise in revenue can indicate operational bloat or aggressive expansion efforts.
The sum of all costs required to run the business that are not directly tied to production, including R&D and SG&A. It r...
Investors compare this to revenue to assess the 'operating leverage' of a business model.
is_total_operating_expenses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $504.50M | $496.20M | $515.60M | $487.50M | $487.50M | $489.00M | $539.50M | $527.90M | $521.60M | $517.60M | $576.10M | $528.30M | $531.90M | $560.20M | $578.20M | $534.30M | $562.70M | $565.00M | $629.10M | $570.40M |
| QoQ Change | — | -1.6% | +3.9% | -5.4% | +0.0% | +0.3% | +10.3% | -2.2% | -1.2% | -0.8% | +11.3% | -8.3% | +0.7% | +5.3% | +3.2% | -7.6% | +5.3% | +0.4% | +11.3% | -9.3% |
| YoY Change | — | — | — | — | -3.4% | -1.5% | +4.6% | +8.3% | +7.0% | +5.8% | +6.8% | +0.1% | +2.0% | +8.2% | +0.4% | +1.1% | +5.8% | +0.9% | +8.8% | +6.8% |